Introduction
GABA, the major inhibitory neurotransmitter of the brain, is thought to play an important role as a signal molecule also outside the nervous system (Erdo and Wolff, 1990) . In particular, evidence for a role of GABA as a paracrine ( Oxford University Press signal molecule in pancreatic islets has been reported (Rorsman et al., 1989 ; for a review see Okada, 1986) . Insulin-secreting fl-cells of the islets, like GABA-secreting neurons (Oertel et al., 198 la,b; Nagai et al., 1984) , contain high levels of GABA (Briel et al., 1972; Okada et al., 1976; Vincent et al., 1983) , of the GABA-synthesizing enzyme glutamic acid decarboxylase (GAD) and of GABAtransaminase (Vincent et al., 1983) . The function and characteristics of the GABA system in the pancreas have become the focus of considerable attention after the demonstration that GAD is a dominant autoantigen in insulin-dependent diabetes mellitus .
GABA-A receptors have been found on a-cells and it has been suggested that these receptors are involved in the inhibition of glucagon release mediated by fl-cells (Rorsman et al., 1989) . A modulatory action of GABA on (-cells has also been reported (Taniguchi et al., 1980) . The direction of blood flow in the islet is consistent with this hypothesis because blood capillaries perfuse first the core of the islet, composed of f-cells, and then the periphery (mantle) of the islet, composed of a-and 6-cells (Bonner-Weir and Orci, 1982) . However, the mechanism of GABA secretion from f-cells is unknown. A previous immunocytochemical study carried out with antibodies directed against GABA had failed to reveal the presence of GABA in insulin-containing granules. This finding suggested that GABA was secreted via a non-vesicular mechanism (Garry et al., 1987) .
It is currently accepted that in the nervous system GABA is concentrated in, and secreted from, synaptic vesicles (Hell et al., 1988) , although a non-vesicular release of GABA at certain specialized regions has been proposed (Schwartz et al., 1987) . Several intrinsic membrane proteins of synaptic vesicles are also present in peptide-secreting endocrine cells (Matthew et al., 1981; Buckley and Kelly, 1985; Wiedenmann and Franke, 1985; Navone et al., 1986; Baumert et al., 1989 Baumert et al., , 1990 . Studies carried out on the pituitary and the adrenal medulla, and on cell lines derived from these tissues, have shown that in endocrine cells these proteins are localized in the membranes of a population of microvesicles distinct from peptide-containing secretory granules (Navone et al., 1986; Navone, 1987; Wiedenmann et al., 1988; Johnston et al., 1989; Baumert et al., 1989 Baumert et al., , 1990 Clift-O'Grady et al., 1990; Cutler and Cramer, 1990; Schweitzer and Paddock, 1990 ; for a review see De Camilli and . These vesicles, referred to as 'synaptic-like microvesicles' (SLMVs) appear to have at least some functional similarities in common with synaptic vesicles of neurons, including the ability to undergo exocytosis, endocytosis and recycling (Johnston et al., 1989; Clift-O'Grady et al., 1990) . The function of SLMVs remains unknown. In view of their similarities with synaptic vesicles, the possibility that SLMVs store and secrete neurotransmitter-like molecules should be considered. Given the proposed paracrine role of GABA in pancreatic islets, fl-cells appeared to be a useful model system to explore this possibility.
The working hypothesis of this study was that secretion of GABA from f-cells is mediated by SLMVs. If this were the case, SLMVs of $-cells should share with synaptic vesicles of GABA-secreting neurons specific properties related to GABA uptake and storage. In this paper evidence supporting this hypothesis is presented. We have demonstrated the existence of SLMVs in :-cells and have shown that, in analogy to the colocalization of GABA and GAD with synaptic vesicles in GABA-secreting neurons, GABA and GAD are colocalized with SLMVs in f-cells. These results represent the first indication that, at least in some endocrine cells, SLMVs might store neurotransmitterlike molecules. This work has been presented previously in abstract format (Reetz et al., 1990a,b) .
Results
SLMVs are present in A-celIs Expression of synaptic vesicle membrane proteins in pancreatic islets had been previously reported (Buckley and Kelly, 1985; Navone et al., 1986; Baumert et al., 1989 Baumert et al., , 1990 , but their precise subcellular localization had not been investigated. An important preliminary step of our study was to demonstrate that in f-cells these proteins are localized on SLMVs, a population of microvesicles distinct from secretory granules. To demonstrate this we used isolated islets as well as cell lines derived from islet cells.
As markers for SLMVs we have used antibodies directed against synaptophysin and p29, two major integral membrane proteins of synaptic vesicles of neurons (Jahn et al., 1985; Wiedenmann and Franke, 1985; Navone et al., 1986; Baumert et al., 1990) . As markers for secretory granules we have used antibodies directed against insulin and secretogranin I. Secretogranin I (also known as chromogranin B) is a peptide stored in secretory granules together with peptide hormones in a variety of peptide-secreting endocrine cells (Rosa et al., 1985b) . Figure la and b shows RINm5F cells (Gazdar et al., 1980; Bhathena et al., 1982) , a commonly used rat insulinoma cell line, double-labeled for p29 and secretogranin I. Secretogranin I immunoreactivity was represented by puncta sparse throughout the cytoplasm and particularly concentrated at the enlarged tips of short thick cellular processes. Electron microscopy immunocytochemistry (not shown), demonstrated that each of these puncta corresponded to individual secretory granules (Rosa et al., 1985a; and not shown). p29 immunoreactivity had a distribution very different from that of secretogranin I (Figure la) but virtually identical to that of synaptophysin (Figure lc and d) . Both p29 and synaptophysin were present at low levels throughout the cell but were particularly concentrated at a paranuclear area, which included the Golgi complex as demonstrated by double-labeling for synaptophysin and GIMPt, an intrinsic membrane protein of the 'trans' region of the Golgi complex (Yuan et al., 1987) (Figure le and f) . The same results were obtained by similar double-labeling experiments carried out on another fl-cell line, fTC3 (Efrat et al., 1988) (Figure  lg and h ). In both cell lines, synaptophysin was not accumulated in the short thick processes rich in secretory granules ( Figure lb and not shown). However, some of the flTC3 cells were found to extend relatively long, often beaded, neurite-like processes. When this was the case, 1276 synaptophysin as well as secretory granule markers, were concentrated in the distal portion of the processes (see Figure   Sc , e and g, Figure 8a and not shown). Fig. 2 . Separation of synaptic vesicle proteins from secretory granules in a continuous sucrose density gradient. A 5000 g supernatant of a total homogenate of RINm5F cells was loaded onto a sucrose gradient ranging from 0.45 to 2 M sucrose. Fifteen fractions were collected starting from the top and equal volumes of such fractions were analyzed by SDS-PAGE and Western blotting with primary antibodies directed against secretogranin I, synaptophysin and p29. Fractions 1-3 correspond to the 'load' of the gradient and contain soluble proteins. Synaptophysin and p29 peak in a lighter portion (0.86-0.95 M sucrose) of the gradient than do secretory granules (1.34-1.47 M sucrose) represented by secretogranin I immunoreactive bands. Some endoproteolytic cleavage of secretogranin molecules is known to take place in parallel with granule maturation (Rosa et al., 1985; Benedum et al., 1987 Figure 2 . Synaptophysin and p29 immunoreactivities peaked near the top of the gradient [density 0.86-0.95 M sucrose, similar to the density previously described for neuronal synaptic vesicles ]. Secretogranin I immunoreactivity was accounted for by several bands as typically seen for proteins of the chromogranin/secretogranin family which undergo partial proteolytic processing during granule condensation (Rosa et al., 1985b; Benedum et al., 1987) . Mature secretory granules, represented by the proteolytically processed form of secretogranin I, peaked in the dense portion (1.34-1.47 M sucrose) of the gradient and were well separated from the peak of synaptophysin. Qualitatively similar results were obtained when subcellular fractionation was performed on a Percoll gradient (not shown). This distribution confirms that synaptophysin and p29 are localized on an organelle distinct from secretory granules.
The morphology of synaptophysin-positive organelles in the endocrine pancreas was investigated by immunogold electron microscopy. Figure 3 shows agarose-embedded fragments of rat islets labeled for synaptophysin. Fragments of f-and a-cells were identified by the typical morphological features of their secretory granules (Williams and Porte, 1974) . These have a characteristic dense core surrounded by a clear halo in -cells and a homogeneous granular content in a-cells (Williams and Porte, 1974) . As demonstrated in Figure 3a , b and c, mature insulin-containing granules were devoid of synaptophysin immunoreactivity. The predominant pool of synaptophysin immunoreactivity was concentrated on the membranes of pleiomorphic clear microvesicles and tubules, with the same characteristics of SLMVs previously identified in other endocrine cells. When fragments of the Golgi complex were visible, synaptophysin immunoreactivity was always present, but confined to its 'trans' side, where it was localized both on vesicles and on cistemal and tubular elements ( Figure 3d ). Synaptophysin was not detected at a significant concentration on the plasma membrane. In conclusion, the localization of synaptophysin in f-cells was similar to that previously observed in other endocrine cells (Navone et al., 1986; Baumert et al., 1990 (Legay et al., 1987; Chang and Gottlieb, 1988; Erlander et al., 1990) which are expressed both in the brain and in the pancreas . GAD is not an integral membrane protein (Kobayashi et al., 1987; Julien et al., 1990; Katarova et al., 1990; Wyborski et al., 1990 ) but exhibits some hydrophobic properties which night be consistent with membrane association Christie et al., 1990 (Figure 4) . GAD was also not detected in RINm5F cells (Figure 4 ). While they are often used as a model for f-cells, recent evidence suggests that RINm5F cells exhibit some characteristics typical of at-cells (Halban et al., 1988) . It is noteworthy that RINm5F cells were previously found to be negative for the 64 kd antigen of insulin-dependent diabetes (Colman et al., 1987) , now known to be identical to GAD .
The distribution of GAD in the OTC3 cell line was investigated by immunofluorescence and compared with the distribution of a marker protein of SLMVs, synaptophysin, GAD immunoreactivity was detected only in a subpopulation of cells which included all the cells with neurite-like processes (Figure 5a -h, see also Figure 8 ). Within GADpositive cells, the distribution of GAD and of synaptophysin was very similar (Figure 5a-h) . GAD, like synaptophysin, was concentrated in the Golgi complex area and in the distal portions of neurite-like extensions. The virtually identical distribution of the two antigens was particularly impressive in the tips of the processes as shown at higher magnification in Figure Se-h. The colocalization of GAD with synaptophysin visible in the processes was similar to the colocalization of the same two antigens in axons and growth cones of primary neuronal cultures double-labeled by the same procedure ( Figure Si -1) .
The subcellular localization of GAD in pancreatic fl-cells was further investigated using electron microscopy colloidal gold immunocytochemistry on agarose-embedded tissue fragments of pancreatic islets. Gold particles were found to be concentrated in proximity to the membranes of pleiomorphic microvesicles and of tubular and cisternal elements ( Figure 6 ). The latter were, in general, in close proximity to the Golgi complex. This localization of GAD was similar to the localization of synaptophysin in the same cells. However, in the case of GAD, a low level of GAD immunolabeling was observed throughout the cytoplasm.
When the same immunocytochemical technique was applied to cerebellar tissue fragments, a low level of immunolabeling was observed throughout the cytoplasm of GABA-secreting neurons. Very intense immunolabeling was observed in nerve terminals. Within nerve terminals gold labeling was primarily associated with synaptic vesicles, while other nerve terminal membranes were virtually unlabeled ( Figure 7) .
The interaction of GAD with brain synaptic vesicles and with SLMVs of f-cells was investigated by subcellular fractionation. However, GAD could not be recovered on synaptic vesicles or on SLMVs purified by immuno-isolation (Burger et al., 1989) , and GAD did not copurify with synaptic vesicles or with any other membranous organelle in sucrose density gradients or in glycerol velocity gradients (unpublished observations). These findings suggested that the interaction between GAD and vesicles is either indirect or highly sensitive to homogenization conditions.
GABA is colocalized with SLMVs in ,B-cells Antibodies specific for GABA have proved to be a useful tool to identify sites where GABA is present at high concentration by immunocytochemistry. Immunostaining of brain sections with antibodies directed against GABA results in the selective labeling of GABA-ergic nerve terminals, i.e. of nerve terminals containing synaptic vesicles specialized for the storage of GABA (Storm-Mathisen et al., 1983). If SLMVs of fl-cells contain GABA in a concentrated form, then GABA immunoreactivity should colocalize with SLMVs. When ,BTC3 cells were labeled with antibodies directed against GABA, immunoreactivity was found to be particularly high in cells with neurite-like processes, and in these cells it was preferentially localized in these processes (Figure 8b and d) . Double-staining of these cells for GABA and for synaptophysin resulted in a very similar immunostain within the processes (Figure 8a and b) , while a detectable accumulation of GABA immunoreactivity was not seen in the region of the Golgi complex. Double-staining of the same cells for GABA and for GAD demonstrated that the cells containing high levels of GABA were the same as those expressing high levels of GAD (Figure 8c and d) . GABA immunoreactivity was not detected in the ctTC1 cells, the GAD-negative a-cell line (see above).
Discussion
Over the last several years growing evidence for a paracrine role of GABA in pancreatic islets has accumulated. GABA is thought to be released from $-cells and to act on a-and possibly b-cells, but until now its mechanism of secretion was unknown (Taniguchi et al., 1980; Robbins et al., 1981; Cavaginini et al., 1982; Passariello et al., 1982; Rorsman et al., 1989 al., 1986; De Camilli and Navone, 1987; Wiedenmann et al., 1988; Baumert et al., 1989 Baumert et al., , 1990 Clift-O'Grady et al., 1990; Cutler and Cramer, 1990; Fischer von Mollard et al., 1990; Schweitzer and Paddock, 1990) . Like synaptic vesicles they undergo exocytosis, endocytosis and recycling (Navone et al., 1986; Johnston et al., 1989; Clift-O'Grady et al., 1990 ). SLMVs were previously described in chromaffin and pituitary cells and are shown by this study to be present in cells of the endocrine pancreas.
The similarities between SLMVs of endocrine cells and neuronal synaptic vesicles strongly suggest that the function of the two organelles is somehow related. The function of synaptic vesicles is to store and secrete non-peptide neurotransmitter molecules (Hokfelt et al., 1984) . In this study we (Kobayashi et al., 1987; Katarova et al., 1989; Julien et al., 1990; Wyborski et al., 1990) . However, a significant pool of GAD partitions in the detergent phase after Triton X-1 14 extraction , suggesting the existence of post-translational hydrophobic modifications of the molecule. These modifications may mediate a membrane attachment labile to homogenization conditions. The nature of the association between GAD and vesicle membranes needs to be further investigated. This issue deserves special interest because it may provide some clues concerning the properties of GAD as a major autoantigen in Stiff-Mann syndrome and insulin-dependent diabetes mellitus Baekkeskov et al., 1990) .
We have also demonstrated here that GABA is concen- (Navone et al., 1986; Baumert et al., 1990 ; this study). In endocrine cells in situ, and in cultured endocrine cells devoid of neurite-like processes, SLMVs are scattered throughout the cytoplasm but are primarily concentrated in the region of the Golgi complex. In these regions they are localized at the trans-side and occupy a space which includes the trans-Golgi network (Navone et al., 1986; Baumert et al., 1990; Schweitzer and Paddock, 1990 ; this study). The localization of SLMVs in the Golgi complex area is thought to reflect the transit of recycling SLMV membranes, because after incubation of PC 12 cells in the presence of extracellular tracers, tracerpositive SLMVs rapidly appear in this region (Johnston et al., 1989; De Camilli and Jahn, 1990) . If SLMVs are indeed involved in a regulated release of signal molecules, lack of a significant accumulation of SLMVs under the plasmalemma suggests that regulation of SLMV exocytosis differs from regulation of synaptic vesicle exocytosis. This is not unexpected given the different characteristics of endocrine and synaptic signalling. A large reserve pool of vesicles in the proximity of release sites might be needed in nerve terminals but not in endocrine cells.
In cultured endocrine cells which extend neurite-like processes, SLMVs are concentrated in the distal portions of the processes. This property, which was shown previously for other endocrine cells (Tooze et al., 1989; Schweitzer and Paddock, 1990) , and is shown here for f-cells, further emphasizes the relationship between SLMVs and synaptic vesicles, because synaptic vesicles accumulate in the distal axonal arbour. It has been shown that axonal differentiation of a neuronal process occurs only after it has reached a critical length (Goslin and Banker, 1989) . Thus, it was of interest that in f-cells, SLMVs were concentrated only in the distal portions of processes with neurite-like characteristics (long, often beaded processes) but not in short, thick cellular extensions. In contrast, both types of processes were enriched in secretory granules, as typically seen in processes of endocrine cells (Tooze and Burke, 1987) . Accumulation of SLMVs in the distal portions of neuritelike processes might reflect a local exo-endocytotic recycling similar to the well known local exo -endocytotic recycling of synaptic vesicles in neuronal axons.
The colocalization of GABA with SLMVs was particularly impressive in the neurite-like processes where both GABA and SLMVs were present at the highest concentrations. In contrast, GABA was not colocalized with synaptic vesicle markers in the region of the Golgi complex. This observation may suggest that the property to take up GABA operates primarily in SLMVs located at the cell periphery, possibly SLMVs ready for exocytosis.
Concluding remarks
The existence of a variety of important biochemical and functional similarities between peptide-secreting endocrine cells and neurons is well known (Grazl and Langley, 1990) . These similarities had led in the past to the speculation that most peptide-secreting endocrine cells and neurons have a common embryological origin from the neural crest (Pearse, 1977) . It is now clear that at least some endocrine cells, including cells of pancreatic islets, are of endodermal origin (Le Douarin, 1988 ). Yet, a close relationship between pancreatic endocrine cells and neurons has been shown (Polak et al., 1984; Navone et al., 1986; Eisenbarth et al., 1987; Teitelman et al., 1987a,b; Alpert et al., 1988; Baumert et al., 1989 Baumert et al., , 1990 . The identification of SLMVs in endocrine cells is a novel important element of similarity between endocrine cells and 1282 neurons. We have previously hypothesized that synaptic vesicles may represent a neuron-specific adaptation of SLMVs (De Camilli and Navone, 1987; De Camilli and Jahn, 1990 ). Our present results, suggesting a role of SLMVs of f-cells in the storage and secretion of the neurotransmitter GABA, strengthen this hypothesis. Studies aimed at providing a direct biochemical demonstration of the presence of GABA and GABA-uptake mechanisms in SLMVs of $-cells are currently under way in our laboratory.
It will be of interest to determine whether SLMVs of all endocrine cells contain non-peptide substances with paracrine/endocrine functions. Different neuronal subpopulations differ in their neurotransmitter phenotype.
Expression of the GABA system only in a subpopulation of endocrine cells, and, more specifically, of a subpopulation of cells of the endocrine pancreas, is consistent with the possibility that a similar heterogeneity applies to endocrine cells. The property to co-secrete peptide and non-peptide signal molecules might be a general characteristic of neurons and endocrine cells.
Materials and methods

Animals
Sprague -Dawley rats weighing -150 g were purchased from Charles River.
Antibodies
The following antibodies were obtained as generous gifts: affinity-purified polyclonal antibodies directed against p29 ) and monoclonal and affinity-purified polyclonal antibodies directed against synaptophysin (Navone et al., 1986 ) from R.Jahn (Munich); polyclonal and monoclonal antibodies directed against secretogranin I (Rosa et al., 1985b) from W.Huttner (Heidelberg); a sheep serum directed against GAD (Oertel et al., 1981a ) from E.Mugnaini (Storrs, CT); a monoclonal antibody against GAD (Chang and Gottlieb, 1988 ) from D.Gottlieb (St Louis, MO); a rabbit serum directed against GAD (Katarova et al., 1989 ) from Z.Katarova and R.J.Greenspan (Nutley, NJ); a rabbit antibody directed against GABA (Wenthold etal., 1986 ) from R.J.Wenthold (Washington, DC); a monoclonal antibody directed against GIMPt (Yuan et al., 1987) from Dr C.A.
Suarez-Quian (Washington, DC). Human antibodies directed against GAD were obtained from the cerebrospinal fluid of a patient affected by Stiff-Mann syndrome . The following immunological reagents were purchased: anti-insulin (chicken) and anti-chicken IgG (goat) sera (Sera Lab, Westbury, NY); anti-rabbit IgG (goat), anti-sheep IgG (goat) and normal (goat) sera (Cappel, Westchester, PA); anti-mouse IgG (goat) (Sigma, St Louis, MO). Protein A-colloidal gold conjugates (4-8 nm) were prepared as described in Slot and Geuze (1983) . 5 nM gold-conjugated anti-human IgGs (goat) were from E-Y Laboratories (San Mateo, CA).
Pancreatic cell lines
RINm5F cells (Gazdar et al., 1980; Bhathena et al., 1982) were a kind gift from L.Vallar (Milano) and K.Wollheim (Geneve). They were grown in RPMI 1640 medium supplemented with 10% fetal calf serum as described (Bhathena etal., 1982) . ,3TC3 (Efrat et al., 1988) and aTC 1 cells (Powers etal., 1990) were a kind gift from D.Hanahan (San Francisco, CA). These cell lines were grown in Click medium (Irvine Scientific, Santa Ana, CA) supplemented with 5 % fetal calf serum.
Islet isolation
Islets were isolated from rats as described by Bowen et al. (1980) .
Neuronal cultures
Primary neuronal cultures were prepared from the hippocampi of 18-day-old fetal rats as described by Banker and Cowan (1977) and Bartlett and Banker (1984) . Briefly, hippocampi were dissociated by treatment with trypsin (0.1% for 15 min at 37°C), followed by trituration with a fire-polished Pasteur pipette. Dissociated cells were plated on poly-A-lysine-treated glass coverslips in MEM supplemented with 2 mM glutamine, 1 % HL 1 (Ventrex, Portland, ME), 10% horse serum, 5% fetal calf serum at densities ranging from 16 000 to 50 000 cells/cm2. The following day, coverslips were transferred (upside down) to dishes containing a monolayer of cortical glial cells, so that they were suspended over the glia but not in contact with them (Bartlett and Banker, 1984) . Cells were maintained in MEM without sera, supplemented with 1% HL1, 2 mM glutamine and 1 mg/ml BSA.
Immunofluorescence
Pancreatic cell lines grown on poly-ornithine (100 itg/ml)-coated glass coverslips (50-70% confluency) and primary neurons after 5 days in vitro were used. Cells were fixed for 1 h at 4°C with 4% paraformaldehyde (freshly prepared from paraformaldehyde) in 0.12 M Na-phosphate buffer, pH 7.4. When cells were to be stained with antibodies directed against GABA, glutaraldehyde (0.1% final concentration) was added to the fixative and immunostaining was preceded by a 5 min incubation in 1 % sodium borohydride to quench glutaraldehyde-induced autofluorescence.
The cells were rinsed with phosphate buffer and then permeabilized for 30 min in goat serum dilution buffer (GSDB: 17% goat serum, 0.3% Triton X-100, 0.45 M NaCI, 20 mM Na-phosphate buffer, pH 7.4). They were then double-stained by immunofluorescence using standard procedures involving secondary antibodies coupled to fluorescein and rhodamine (De Camilli et al., 1983; Johnston et al., 1989) . All antibody incubations were performed in GDSB for 2 h at room temperature. Coverslips were mounted in 70% glycerol, 10 mg/ml phenylenediamine in PBS, observed in a Zeiss Axiophot microscope and photographed with T-Max 100 (Kodak). 
Immunoprecipitation assays
Preparation ofcell and tissue extracts. Cells grown in 100 mm dishes were harvested and pelleted as described for sucrose density gradients. The cell pellet was resuspended in (200 ll/dish) ice-cold buffer A (150 mM NaCI, 10 mM HEPES, pH 7.4, protease inhibitors as described above) containing 2% Triton X-100 and incubated on ice for 2 h. Insoluble material was removed by centrifugation (16 000 g for 30 min, 4C). The remaining supernatant was stored at -20°C and used for immunoprecipitations. The protein concentration of the extracts varied between 1.0 and 1.5 mg/mi for the different cell lines. Rat brain and liver were homogenized in 10 vol (w/v) of buffer A using a polytron homogenizer (30 s on ice). The homogenate was then spun at 100 000 g for 60 min at 4°C and the pellet was resuspended in 40 mi of ice cold homogenization buffer containing either Triton X-100 (2% w/v) or Triton X-1 14 (2% w/v) and incubated on ice for 2 h. Insoluble material was removed as described for cells. The Triton X-1 14 supernatant was further processed as described (Bordier, 1981 ). Both Triton X-100 and Triton X-1 14 were diluted 1: 1 in homogenization buffer before use; the final protein concentration was 0.5 mg/ml (Triton X-1 14 brain extract), 1.2 mg/ml (Triton X-100 brain extract) and 0.625 mg/ml (Triton X-1 14 liver extract). Approximately 500 freshly dissociated rat islets were pelleted and resuspended in 500 yI buffer A with 2% Triton X-100. They were further processed as described for cells, above.
Immunoprecipitation. Preclearing of detergent extracts was performed as follows. Control human serum (25 ttl) was added to 0.5 ml of each extract. After 1 h incubation, 100 ul of 50% protein A-Sepharose (Pharmacia, Uppsala, Sweden) was added to each sample, the samples were incubated for an additional hour and centrifuged at 750 g for 1 min. The resulting supernatants were incubated for an additional hour with 100 ul of 50% protein A-Sepharose and centrifuged as described above.
For immunoprecipitation, the following additions were made in sequential order to precleared extracts incubated with rotation: 1.5 /1l of sheep serum directed against GAD or preimmune sheep serum (Oertel et al., 1981a) (16 h), 20 izl of rabbit IgGs directed against sheep IgGs (1.5 h), 125 ud of 50% protein A-Sepharose (1.5 h). The samples were then centrifuged (750 g for 1 min) and the resulting protein A-Sepharose pellets were washed three times in 150 mM NaCI, 10 mM HEPES, pH 7.4. All preclearing and immunoprecipitation steps were carried out at 4°C. The final washed pellet was solubilized in 75 yl of gel sample buffer (Laemmli et al., 1970) (0.0625 M Tris-Cl, pH 6.8, 2% SDS, 10% glycerol, 30 mM DTT, bromophenol blue), heated at 100°C for 3 min, and centrifuged at 16 000 g for 10 min. The supernatants were removed and stored at -20'C.
Immunoprecipitates were analyzed by SDS -PAGE and Western blotting.
Miscellaneous analytical procedures Proteins were measured by the BCA assay (Pierce). SDS-PAGE was performed according to Laemmli et al. (1970) . Western blotting was performed as described by Towbin et al. (1979) using a [1251] protein A (Amersham, Arlington Heights, IL) radioimmunolabeling procedure.
Electron microscopy Electron microscopy immunocytochemistry was performed essentially as described by De Camilli et al. (1983) and modified by Mignery et al. (1989) . Briefly, fresh dissociated rat islets or rat brains were mildly homogenized in 0.25 M sucrose, 25 mM KCI, 10 mM Na-phosphate buffer, pH 7.4, by passing them a few times through a loosely fitting glass-Teflon homogenizer. The resulting tissue fragments were fixed, embedded in agarose, labeled by an immunogold procedure and finally embedded in plastic and processed for electron microscopy observations as described. Affinitypurified antibodies directed against synaptophysin followed by protein A -gold were used for the anti-synaptophysin immunostain. A human CSF containing autoantibodies specifically directed against GAD (Solimena et al., 1980) followed by gold-conjugated goat anti-human IgGs was used for the anti-GAD immunostain. The specificity of these antibodies was previously reported [case no. 161 of Solimena et al. (1990) identical to case no. 2 of Schwartzmann et al. (1991) ].
